Related Experiment Video
Updated: May 2, 2026

05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
1.1K
Prostate cancer in Asian men
1Department of Urology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan.
Nature Reviews. Urology
|March 6, 2014
Summary
Prostate cancer rates are rising in Asia but remain lower than in Western countries. Differences in screening access, not just genetics or diet, likely explain these trends, necessitating tailored management strategies.
Area of Science:
- Oncology
- Epidemiology
- Public Health
Background:
- Prostate cancer incidence and mortality are increasing in native Asian populations.
- Rates are lower than in Asian-American and other American cohorts, with potential influences from genetics, diet, and screening.
- Disparities in screening access may be a significant factor in observed epidemiological differences.
Purpose of the Study:
- To analyze the epidemiological variations in prostate cancer across Asian populations.
- To investigate the contributing factors, including screening, genetics, and environment, to these variations.
- To propose individualized management strategies for prostate cancer in Asian countries.
Main Methods:
- Comparative analysis of prostate cancer incidence and mortality data across different Asian and American cohorts.
- Evaluation of potential contributing factors such as genetic predispositions, dietary patterns (e.g., Western diet), and access to Prostate-Specific Antigen (PSA) screening.
- Assessment of the prevalence of metastatic prostate cancer in various populations.
Main Results:
- Native Asian populations show increasing prostate cancer rates, yet lower than Asian-American and Western cohorts.
- Lower exposure to PSA screening in Asian individuals is a potential key factor, alongside genetic and environmental influences.
- A higher proportion of metastatic prostate cancer is observed in Asian countries compared to Western populations, even in developed Asian nations.
Conclusions:
- Variations in prostate cancer epidemiology among native Asian populations may be linked to differences in access to PSA testing, urology clinics, and therapies.
- Individualized prostate cancer screening and treatment strategies are essential for Asian countries, considering specific epidemiological features and socioeconomic status.
- Addressing disparities in screening and treatment access is crucial for improving prostate cancer outcomes in Asia.
Related Concept Videos
Disorders of the Male Reproductive System
5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K

